Skip to main content
Download PDF
  • Original research
  • Open access
  • Published:

Effects of NaHS and hydroxylamine on the expressions of brain-derived neurotrophic factor and its receptors in rats after cardiac arrest and cardiopulmonary resuscitation

Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine volume 26, Article number: 109 (2018) Cite this article

Abstract

Background

H2S can also protect nerve cells. The objective of the study is to investigate the effects of hydrogen sulfide (H2S) on the expressions of brain-derived neurotrophic factor (BDNF) and its receptors, tyrosine protein kinase B (TrkB) and p75 neurotrophin receptor (p75NTR), in brain tissues of rats with cardiac arrest and cardiopulmonary resuscitation (CA/CPR) following the restoration of spontaneous circulation (ROSC).

Methods

Rats (n = 240) with CA/CPR were divided into three groups: Intervention (n = 80) that received sodium hydrosulfide (NaHS, 14 μmoL/kg·d) intervention after ROSC; Inhibition (n = 80) that received hydroxylamine (40 μmoL/kg·d) intervention after ROSC; and Control (n = 80) that received saline after ROSC. Kaplan-Meyer analysis was used to analyze the survival data. Quantitative real-time PCR (q-PCR), Western blot, immunohistochemistry and IODs (integrated optical density) were performed to determine the mRNA and protein expressions of BDNF, TrkB and p75NTR in rat brain tissues.

Results

Survival rate of the three groups had significant difference (χ2 = 28.376, p = 0.000). The Intervention group had the highest survival rate (82.5%), while the Inhibition group had the lowest survival rate (62.5%). The mRNA and protein levels of BDNF and TrkB in the Intervention group were significantly higher compared to the Control group (p < 0.05); while the mRNA and protein levels of BDNF and TrkB in the Inhibition group was significantly lower than the Control group (p < 0.05) on days 1, 3, and 7. However, the mRNA and protein levels of p75NTR in the Intervention group were significantly lower than the Control group (p < 0.05); while the mRNA and protein levels of p75NTR in the Inhibition group were significantly higher than the Control group (p < 0.05) on days 1, 3, and 7.

Conclusion

NaHS treatment increases the survival rate of rats after CA and ROSC by upregulating the expression and activation of BDNF and its receptor TrkB, and down-regulating p75NTR expression.

Background

Post-cardiac arrest brain injury is a common cause of morbidity and mortality after cardiopulmonary resuscitation (CPR). Studies show that brain injury is the cause of death in 68% of patients after out-of-hospital cardiac arrest and in 23% of patients after in-hospital cardiac arrest [1]. More than half of the survivors have varying degrees of permanent brain injuries [2]. Despite recent advancements in the field of cardiac arrest and resuscitation, the management and prognosis of post-cardiac arrest brain injuries remain suboptimal and require further investigation [3].

Brain-derived neurotrophic factor (BDNF), a member of the neurotrophin family, is widely expressed in the central nervous system (CNS). BDNF binds to neurotrophin (NT) receptors and activates several neuroprotective pathways [4]. There are two types of NT receptors: the original high-affinity myosin receptor kinase (tropomyosin receptor kinase, Trk) and low-affinity receptor of p75 (p75 NT receptor, p75NTR). Both receptors are involved in the regulation of growth, differentiation, repair, apoptosis and survival of cells [5]. Several studies show that the signal transductions involved in Trk and p75NTR have mutually-antagonistic relationship [6]. Trk receptors generally mediate “positive” signals, such as promoting the growth of neurons to ensure their survival [7]. As a BDNF-specific receptor of the Trk family, TrkB belongs to tyrosine protein kinases with extracellular, transmembrane, and intracellular regions. Because the receptor tyrosine kinase domain is in its intracellular region, ligand and receptor binding can induce receptor dimerization and activation of the tyrosine kinase [8]. p75NTR has various biological effects. It promotes neuronal survival and growth, induces neuronal apoptosis [9], inhibits the axonal growth of neurons [10], and regulates cell cycle [11]. Although p75NTR mediates both “positive” and “negative” effects, it mainly mediates “negative” pro-apoptotic effects [12].

Endogenous hydrogen sulfide (H2S), a signaling gas molecule, is involved in ischemia/reperfusion injury [13] and shock development [14]. However, H2S can also protect nerve cells [15]. H2S increases intracellular Ca2+ and induces Ca2+ waves in primary cultures of astrocytes as well as hippocampal slices. H2S modifies hippocampal long-term potentiation (LTP) and functions as a neuromodulator. Studies show that H2S protects PC12 cells (neurocytes derived from pheochromocytoma of adrenal medulla of rat) [16] and hippocampal slices [17] against oxidative damage and toxicity by regulating BDNF-TrkB pathway, suggesting a close association of H2S and BDNF-TrkB pathway in CNS. Here we hypothesized that H2S may have impact on rats’ survival after CA and ROSC by regulating BDNF/TrkB/p75NTR pathway.

In our study, we established CA rat model using transcutaneous electrical stimulation. We modulated the endogenous H2S level in CA rats after CPR by intravenous injection of NaHS, and measured the expressions of BDNF, TrkB and p75NTR in brain tissues to investigate cause-and-effect relationship between NaHS, BDNF, TrkB and rats’ survival.

Materials and methods

Experimental groups

All animal experiments were performed according to the American experimental animal use guidelines (NIH Publications No. 80–23) and approved by the animal ethics committee of Xiamen University. Healthy male Sprague-Dawley rats (n = 240; age of 6–12 months; weight of 300–500 g) were provided by the experimental animal center of Xiamen University. The rats were divided into three groups: Intervention (n = 80), Inhibition (n = 80) and Control (n = 80). Twelve CA/CPR rats with successful ROSC were randomly and double-blindly selected from the surviving rats of these three groups on days 0, 1, 3, and 7, and served as subgroups for the result analysis. If there were more than 12 rats on the 7th day, only 12 rats were included in the 7-day subgroups. The general physiological characteristics of rats are shown in Table 1 and the rats’ survivals data are shown in Fig. 1.

Table 1 The baseline characteristics of the rats in all of the subgroups after restoration of spontaneous circulation (x ± s)
Full size table
Fig. 1
figure 1

Serum hydrogen sulfide (H2S) concentrations in rats after cardiac arrest and cardiopulmonary resuscitation following restoration of spontaneous circulation. *p < 0.05

Full size image

Establishment of CA/CPR rat model, ROSC and samples preparation

CA rat model was established based on our previously reported method [18]. The ROSC rats received intervention immediately after ROSC as described in Section 2.3. ECG and hemodynamic monitoring were performed for 4 h. During the 4 h monitoring period, the rats with weak spontaneous breathing (PaCO2 < 60 mm mmHg) were continuously mechanically ventilated without any treatment. The breathing pattern was assessed every 15 min to decide whether to continue the mechanical ventilation [18]. If the rats were awake during the procedure, we intraperitoneally injected 3% sodium pentobarbital (30 mg/kg). After 4 h, mechanical ventilation was stopped, all tubes were removed and wounds were sutured. The rats were observed for 7 d. All the selected rats were intraperitoneally injected with 3% sodium pentobarbital (30 mg/kg). Cardiac puncture method was used to obtain 2–5 mL blood. All of the rats were killed by decapitation, and 3 mm brain tissues including cortex, hippocampus, and cerebellum were harvested, fixed in formaldehyde, and embedded in Paraffin.

Intervention methods

The rats in Intervention group were intravenously injected with 1 mL sterile NaHS (a donor for H2S, CAS: 140650–84-6, Sigma, USA) at a dose of 14 μmoL/kg·d at 1 h after ROSC. The rats in Inhibition group were intravenously injected with 1 mL sterile diluted hydroxylamine (an inhibitor for H2S, CAS 7803-49-8, Sigma) at a dose of 40 μmoL/kg·d at 1 h after ROSC. The doses of NaHS and hydroxylamine were chosen based on our previous study and other references [19] [20] [21]. The rats in Control group received 1 mL sterile saline at 1 h after ROSC.

Specimen collection

Before all the rats were euthanized, 1 mL of femoral vein blood sample was collected and added into 1 mL Eppendorf (EP) tubes with a coagulant agent. The blood samples were centrifuged at 4000 r/min for 15 min at 4 °C. The supernatant was collected, coded, and stored at − 80 °C for serum H2S determination.

For each subgroup, six rats were perfused with saline through the heart, followed by 4% paraformaldehyde for 30 min. The brains were removed, fixed in 4% paraformaldehyde, embedded in paraffin, and sectioned for immunohistochemistry assay. For the other six rats, hippocampus tissues were harvested, snap-freezing in liquid nitrogen, and stored at − 80 °C for quantitative real-time PCR and Western blot analyses.

Serum hydrogen sulfide determination

A H2S kit (BC2055, Solarbio, Beijing China) was used to detect the H2S level. The following reagents were added in a 5 mL glass tube: 0.5 mL of 1% (W/W) zinc acetate, 2.5 mL of distilled water, 0.1 mL of serum sample or NaHS·H2O (CAS: 140650–84-6, Sigma), 0.5 mL of 20 mM (7.2 M HCl) dimethyl-p-phenylenediamine sulfate, and 0.4 mL of 30 mM (1.2 M HCl) ferric chloride. The reagents were mixed and transferred to an incubator at 37 °C for 20 min to allow a complete color change. The mixtures were added with 1 mL 10% trichloroacetic acid, and then diluted with distilled water for a final volume of 5 mL. The mixtures (5 mL) were centrifuged at 12,000 rpm for 10 min. The supernatants were collected and measured at an absorbance of 620 nm. Linear regression equation was used to calculate the serum H2S concentration. Each serum sample was measured 3 times, and the concentration of each sample was the mean of the three measurements. The final concentration (μmol/L) of H2S in each group was averaged and presented as mean ± standard deviation.

Quantitative real-time PCR

The mRNA expressions of BDNF, TrkB, and p75NTR were measured by quantitative real-time PCR. Total RNA was isolated from the brain tissues using an RNeasy kit with Trizol (Invitrogen, USA), and reverse-transcribed into cDNA using a reverse transcription kit with M-MLV polymerase (Promega, USA). The sequence-specific primers used were as follows: BDNF-F, 5′-CGATTAGGTGGCTTCATAGGAG-3′ and BDNF-R, 5′-ACGAACAGAAACAGAGGAGAGATT-3′; TrkB-F, 5′-CAAGTTGGCGAGACATTCCA-3′ and TrkB-R, 5′-AGTCATCGTCGTTGCTGATGAC-3′; p75NTR-F, 5′-TTCCTTAGCCCCTCCCTTCT-3′ and p75NTR-R, 5′-CCTGCCTTTCTCTGGGTTTTAC-3′; ACTIN-F, 5′-GCTATGTTGCCCTAGACTTCGA-3′ and ACTIN-R, 5′-GATGCCACAGGATTCCATACC-3′. PCR was performed using an IQ5 PCR System (Bio-Rad, USA) with an initial denaturing step at 95 °C for 15 s, 45 cycles of denaturing at 95 °C for 5 s, and annealing at 60 °C for 30 s. The relative expressions of genes were determined using the ΔΔCt method [22] to normalize the target gene expression to that of the housekeeping gene (ACTIN).

Western blot

The protein expressions of BDNF, TrkB, and p75NTR were measured by Western blot. Lysis buffer [400 μL; 50 mM Tris-HCl, pH 7.4, 150 mM NaCl, 1% nonidet P-40, 0.5% deoxycholic acid, 0.1% sodium dodecyl sulfate (SDS), 5 mM ethylenediaminetetraacetic acid, 2 mM phenylmethylsulfonyl fluoride, 20 μg/mL of aprotinin, 20 μg/mL of leupeptin, 10 μg/mL of pepstanin A, and 150 mM benzamidine] was added into 100 mg of brain tissues, and homogenized for 30 min on ice. The homogenate was transferred into 1.5 mL EP tubes and centrifuged at 12,000 rpm for 5 min at 4 °C. The supernatant was collected. Protein quantification was performed using the bicinchoninic acid method, and SDS-polyacrylamide gel electrophoresis was performed. The proteins were transferred onto polyvinylidene fluoride membranes, probed with appropriate primary and secondary antibodies, and then detected using a Pierce Fast Western Blot Kit ECL Substrate (Cat No. 35055, Thermo, USA). The primary antibodies (1:1000 dilution) used were as follows: rabbit anti-rat BDNF (H-117) (sc-20,981, Santa Cruz Biotechnologies, USA), rabbit anti-rat TrkB (H-181) (sc-8316, Santa Cruz Biotechnologies), rabbit anti-rat p75NTR (H-92) (sc-5634, Santa Cruz Biotechnologies), and rabbit anti-rat α-tubulin (sc-5546, Santa Cruz Biotechnologies). The secondary antibody (1:5000) used was goat anti-rabbit IgG (sc-2004; Santa Cruz Biotechnologies). Immunoreactivity was imaged using Perfection 3490 photo gel imaging systems (Epson, Japan) and analyzed using Image Pro PLUS (Media Cybernetics, USA). Protein expression was normalized to tubulin.

Immunohistochemistry

The protein expressions of BDNF, TrkB and p75NTR in the cortex, hippocampus, and cerebellum were detected by immunohistochemistry. Paraffin-embedded tissues were sectioned at a thickness of 10 μm and mounted onto a 1.35-μm thin polyethylene film (PALM GmbH; Wolfratshausen, Germany) overlaid on a glass slide. Sections were incubated with primary antibodies overnight at 4 °C. After wash, the sections were incubated with biotinylated goat anti-rabbit IgG (1:5000, sc-2004; Santa Cruz Biotechnologies) for 30 min. Positive staining was revealed using diaminobenzidine [SABC immunohistochemical staining kit (Cat. No. SA1025), Wuhan Boster Biological Engineering Co., Ltd., China)] according to the manufacturer’s instructions. The primary antibodies (1:1000 dilution) used were as follows: rabbit anti-rat BDNF (H-117) (sc-20,981, Santa Cruz Biotechnologies), rabbit anti-rat TrkB (H-181) (sc-8316, Santa Cruz Biotechnologies), and rabbit anti-rat p75NTR (H-92) (sc-5634, Santa Cruz Biotechnologies). The immunostained slides were imaged using Imaging-Pro Plus 6.0 [23]. Five fields were randomly selected in each section for integrated optical density (IOD) calculations. The IOD of each slice was the mean IOD of the five fields.

Statistical analysis

SPSS 13.0 statistical package was used for statistical analysis. All the values were presented as mean ± standard error. Multi-comparisons between means were analyzed by the Student-Newman-Keuls method. p < 0.05 was considered statistically significant. Survival data were analyzed by Kaplan-Meyer Analysis method and Log Rank (Mantel-Cox) was used to compare the survival difference.

Results

General physiological characteristics of rats

A total of 240 rats were used for the CA/CPR model. However, some rats died during ROSC or within the 7-d observation period. Thus, only 12 rats were selected on days 0, 1, 3, and 7 for the final analysis. The general physiological characteristics of the rats are shown in Table 1. After ROSC, no significant difference was found among the baseline characteristics of the rats in all the subgroups (p > 0.05).

Comparison of serum H2S concentrations

The average serum H2S concentrations of all the subgroups were calculated (Fig. 1). There was no significant difference in the average H2S concentrations on day 0 (p > 0.05). After NaHS·H2O stimulation, the serum H2S concentrations in the Intervention group gradually increased over time (Fig. 1) and were significantly higher than the Control group (p < 0.05). Because the H2S formation in the Inhibition group was inhibited by hydroxylamine (Fig. 1), the serum H2S concentrations in Inhibition group was significantly lower than the Control group (p < 0.05), and were maintained at a low level during the 7-d observation period.

Kaplan-Meyer analysis of survival rate

Survival rate was 82.5% (66/80) in Intervention group, 62.5% (50/80) in Inhibition group, and 71.3% (57/80) in Control group. The 95% CI of survival time was 6.015~6.753 days in Intervention group, 5.429~6.281 days in Inhibition group, and 5.728~6.520 days in Control group, which had a significant difference (χ2 = 8.683, P = 0.013) (Fig. 2).

Fig. 2
figure 2

Kaplan-Meyer Analysis of survival rate. The survival curve indicates that the Intervention group (blue line) had the highest survival rate, compared to the Inhibition group (green line) and the Control group (yellow line). The analysis was performed from day 0 to day 7 (censored)

Full size image

Comparison of the relative mRNA expression levels of BDNF, TrkB, and p75NTR in the brain tissues

The relative mRNA expression levels of BDNF, TrkB and p75NTR in the brain tissues of CA/CPR rats after ROSC decreased over time during the 7-d observation period (Fig. 3). There was no significant difference in mRNA expression of BDNF, TrkB, and p75NTR among the three groups at 0-d after CPR (Fig. 3a-c). The mRNA levels of BDNF and TrkB were similar on days 0, 1, 3, and 7 in the Intervention group (Fig. 3a, b) (p > 0.05). However, the mRNA levels of BDNF and TrkB on days 1, 3, and 7 in the Intervention group were significantly higher than the Control group (p < 0.05). In contrast, the mRNA levels of BDNF and TrkB decreased over time in the Inhibition group and were significantly lower than the Control group (p < 0.05). The mRNA levels of p75NTR in the Inhibition group were significantly higher on days 1 and 3 than day 0, and also significantly higher than the Control group on days 1 and 3. In contrast, the mRNA level of p75NTR in the Intervention group decreased daily, and significantly decreased on days 1 and 3 compared with the Control group (p < 0.05).

Fig. 3
figure 3

Comparison of the relative mRNA expression of (a) BDNF, (b) TrkB, and (c) p75NTR in brain tissues. *p < 0.05, Intervention versus Control; †P < 0.05, Inhibition versus Control

Full size image

Relative protein expressions of BDNF, TrkB, and p75NTR in brain tissues

There was no significant difference in the relative protein expressions of BDNF, TrkB, and p75NTR among the three groups on day 0 (Fig. 4). The expressions of BDNF and TrkB in the Intervention group decreased over time (Fig. 4a and b), but were significantly higher than the Control group on days 1, 3, and 7 (p < 0.05). The relative protein expressions of BDNF and TrkB in the Inhibition group decreased significantly than the Control group (p < 0.05) over time. In addition, the relative protein expression of p75NTR in the Intervention group significantly increased on days 1, 3, and 7, compared with the Control group (P < 0.05). In contrast, the relative protein expression of p75NTR in the Inhibition group reduced significantly compared with the Control group (p < 0.05).

Fig. 4
figure 4

Comparison of the relative protein expression of (a) BDNF, (b) TrkB, and (c) p75NTR in brain tissues. *p < 0.05, Intervention versus Control; †P < 0.05, Inhibition versus Control

Full size image

Immunohistochemical staining of BDNF, TrkB, and p75NTR in the cerebral cortex, hippocampal tissue, and cerebellum

The expressions of BDNF, TrkB and p75NTR in the cerebral cortex, hippocampal tissue, and cerebellum of CA/CPR rats after ROSC decreased over time during the 7-d observation period (Figs. 5 and 6). There was no significant difference in the IODs of BDNF, TrkB, and p75NTR in the cerebral cortex (Fig. 5A1-A3 and Fig. 6 A1-A3), hippocampal tissue (Fig. 5B1-B3 and Fig. 6B1-B3), and cerebellum (Fig. 5C1-C3 and Fig. 6C1-C3) among the three groups at 0-d after CPR. These findings are consistent with the imaging results (Fig. 6). On days 1, 3, and 7, the IODs of BDNF and TrkB significantly increased in the Intervention group (p < 0.05), but significantly decreased in the Inhibition group (p < 0.05), compared with the Control group. In contrast, the IOD of p75NTR significantly decreased in the Intervention group (p < 0.05), but significantly increased in the Inhibition group (p < 0.05) on days 1, 3, and 7.

Fig. 5
figure 5

Integrated optical density of BDNF, TrkB, and p75NTR in cerebral cortex (A1, A2, and A3), hippocampal tissues (B1, B2, and B3) and cerebellum (C1, C2, and C3)

Full size image
Fig. 6
figure 6

Immunohistochemical staining of BDNF, TrkB, and p75NTR in cerebral cortex (A1, A2, and A3), hippocampal tissues (B1, B2, and B3) and cerebellum (C1, C2, and C3)

Full size image

Discussion

A post-cardiac arrest syndrome due to ischemic encephalopathy occurs after cardiac arrest, which aggravates sickness and often results in death [24]. Most CA patients after ROSC become comatose or suffer from chronic neurological disability [25]. A high percentage of survivors exhibit permanent cognitive dysfunction and poor social behavior with a lower quality of life [26]. During CPR, brain damage can occur during ischemia and reperfusion periods due to the interrupted cerebral blood flow. Although the mechanisms involved in ischemia and reperfusion periods differ, nerve cell death occurs during both of these two periods [27]. Early intervention, which is used to delay the onset of cell death, can increase the survival rate of patients.

H2S can protect nerve cells by improving the blood circulation in the brain [28]. Studies show that physiological H2S concentration can clear peroxynitrite (ONOO–), reduce neuronal damage mediated by ONOO– [29], and inhibit oxidative stress to protect the nervous system by increasing mitochondrial reduced glutathione (GSH) levels [30]. In addition, intravenous injection of NaHS [H2S donor [31]] can prevent neuronal damage [32] and hypochlorous acid-induced PC12 cell injury [33]. Our results indicate that intravenous injection of NaHS·H2O effectively increased the H2S concentration in the serum of CA/CPR rats after ROSC; while hydroxylamine inhibited H2S formation. These findings are consistent with those of Wallace et al. [34]. Meanwhile, Kaplan-Meyer analysis showed that the survival time of the Intervention group was significantly higher than the Control group, while the survival time of the Inhibition group was significantly lower than the Control group. All the above results indicate that NaHS·H2O injection can improve the survival time after ROSC, while hydroxylamine can accelerate the death.

As a member of the neurotrophic factor family, BDNF is widely distributed in the nervous system, the endocrine system, and other organs and tissues. BDNF is mainly expressed in the neurons of the nervous system, with the highest concentrations found in the cerebral cortex and hippocampus. BDNF plays an important role in neuronal survival, differentiation, growth, and development. BDNF also plays a crucial role in preventing neuronal injury, improving the pathological state of neurons, and promoting the regeneration of injured neurons. Our results demonstrate that intravenous injection of NaHS·H2O effectively increased BDNF expression, while hydroxylamine inhibited BDNF expression. H2S is considered as an antioxidant that can decrease oxidative stress [35] and increase BDNF expression in the hippocampus of rat model of brain injury [17].

Recent studies have shown that the expressions of BDNF and its receptor TrkB increase in ischemia/reperfusion injury of the brain [36, 37]. BDNF can inhibit caspase-3 activity and regulate the expressions of bcl-2 and bax to inhibit cell apoptosis [38]. TrkB upregulation enhances the effect of BDNF on neuronal growth. Moreover, the activation of TrkB receptor can block the effects of intracellular damage factor on protein kinase C activity to prevent neuronal degeneration and necrosis [39]. p75NTR expression also increases during injury, and inhibiting p75NTR signaling can delay disease progression and promote cell survival [40]. p75NTR-induced apoptosis is obtained by binding with BNDF and activating the c-Jun and N-terminal kinase pathway [41]. In this study we investigated the impact of NaHS-induced changes in BDNF and its receptor (TrkB and p75NTR) on rats’ survival after CA and ROSC. Our results suggest that intravenous injection of NaHS·H2O can effectively increase TrkB expression and inhibit p75NTR expression; whereas, hydroxylamine had the opposite effects on TrkB and p75NTR expressions.

In conclusion, in this study we demonstrate that intravenous injection of NaHS·H2O can increase the level of BDNF and TrkB, while decrease p75NTR in the brain tissues of CA/CPR rats after ROSC, leading to an increased survival time of the rats. In contrast, hydroxylamine (cystathionine-β-synthase inhibitor) decreased BDNF and TrkB levels and increased p75NTR, leading to decreased survival time of the rats. Therefore, NaHS may have neuroprotective effects by promoting the BDNF/TrkB signaling pathway.

Limitations

There are some limitations in this study. Firstly, the age of the rats was variable (6–12 months). However, we did not find an association between the age and the survival time of the CA model. Secondly, we only demonstrate that H2S can modulate the levels of BDNF and its receptors in ROSC rats, leading to an increased survival time; however, the underlying mechanisms need to be investigated in our future studies.

References

  1. Laver S, Farrow C, Turner D, Nolan J. Mode of death after admission to an intensive care unit following cardiac arrest. Intensive Care Med. 2004;30(11):2126–8.

    Article  Google Scholar 

  2. Green RS, Howes D. Hypothermic modulation of anoxic brain injury in adult survivors of cardiac arrest: a review of the literature and an algorithm for emergency physicians. Cjem. 2005;7(1):42–7.

    Article  Google Scholar 

  3. Reis C, Akyol O, Araujo C, Huang L, Enkhjargal B, Malaguit J, Gospodarev V, Zhang JH. Pathophysiology and the monitoring methods for cardiac arrest associated brain injury. Int J Mol Sci. 2017;18(1).

  4. Proenca CC, Song M, Lee FS: Differential effects of BDNF and neurotrophin 4 (NT4) on endocytic sorting of TrkB receptors. J Neurochem 2016, 138(3):397–er406.

  5. Noh SJ, Kim KM, Jang KY. Individual and co-expression patterns of nerve growth factor and heme oxygenase-1 predict shorter survival of gastric carcinoma patients. Diagn Pathol. 2017;12(1):48.

    Article  Google Scholar 

  6. Greenwood SG, Montroull L, Volosin M, Scharfman HE, Teng KK, Light M, Torkin R, Maxfield F, Hempstead BL, Friedman WJ. A novel neuroprotective mechanism for Lithium that prevents association of the p75(NTR)-Sortilin receptor complex and attenuates proNGF-induced neuronal death in vitro and in vivo. eNeuro. 2018;5(1).

  7. Puehringer D, Orel N, Luningschror P, Subramanian N, Herrmann T, Chao MV, Sendtner M. EGF transactivation of Trk receptors regulates the migration of newborn cortical neurons. Nat Neurosci. 2013;16(4):407–15.

    Article  CAS  Google Scholar 

  8. Purba ER, Saita EI, Maruyama IN. Activation of the EGF receptor by ligand binding and oncogenic mutations: the “rotation model”. Cells. 2017;6(2):13.

    Article  Google Scholar 

  9. Song W, Volosin M, Cragnolini AB, Hempstead BL, Friedman WJ. ProNGF induces PTEN via p75NTR to suppress Trk-mediated survival signaling in brain neurons. J Neurosci. 2010;30(46):15608–15.

    Article  CAS  Google Scholar 

  10. Almeida RD, Duarte CB: p75NTR Processing and Signaling: Functional Role: Springer New York; 2014.

  11. Pincheira R, Baerwald M, Dunbar JD, Donner DB. Sall2 is a novel p75NTR-interacting protein that links NGF signalling to cell cycle progression and neurite outgrowth. EMBO J. 2009;28(3):261–73.

    Article  CAS  Google Scholar 

  12. Bagge J, Lorentzon R, Alfredson H, Forsgren S. Unexpected presence of the neurotrophins NGF and BDNF and the neurotrophin receptor p75 in the tendon cells of the human Achilles tendon. Histol Histopathol. 2009;24(7):839–48.

    CAS  PubMed  Google Scholar 

  13. Chen W, Liu N, Zhang Y, Qi Y, Yang J, Deng Z, Li X, Xie X. Exogenous hydrogen sulfide protects against myocardial injury after skeletal muscle ischemia/reperfusion by inhibiting inflammatory cytokines and oxidative stress in rats. Nan Fang Yi Ke Da Xue Xue Bao. 2013;33(4):554–8.

    PubMed  Google Scholar 

  14. Yang B, Bai Y, Yin C, Qian H, Xing G, Wang S, Li F, Bian J, Aschner M, Lu R. Activation of autophagic flux and the Nrf2/ARE signaling pathway by hydrogen sulfide protects against acrylonitrile-induced neurotoxicity in primary rat astrocytes. Arch Toxicol. 2018;92(6):2093–108.

    Article  CAS  Google Scholar 

  15. Nagai Y, Tsugane M, Oka J, Kimura H. Hydrogen sulfide induces calcium waves in astrocytes. FASEB J. 2004;18(3):557–9.

    Article  CAS  Google Scholar 

  16. Jiang JM, Zhou CF, Gao SL, Tian Y, Wang CY, Wang L, Gu HF, Tang XQ. BDNF-TrkB pathway mediates neuroprotection of hydrogen sulfide against formaldehyde-induced toxicity to PC12 cells. PLoS One. 2015;10(3):e0119478.

    Article  Google Scholar 

  17. Hu M, Zou W, Wang CY, Chen X, Tan HY, Zeng HY, Zhang P, Gu HF, Tang XQ: Hydrogen sulfide protects against chronic unpredictable mild stress-induced oxidative stress in Hippocampus by upregulation of BDNF-TrkB pathway. Oxidative Med Cell Longev,2016,(2016-7-25) 2016, 2016(225):2153745.

  18. Lin JY, Liao XX, Li H, Wei HY, Liu R, Hu CL, Huang GQ, Dai G, Li X. Model of cardiac arrest in rats by transcutaneous electrical epicardium stimulation. Resuscitation. 2010;81(9):1197–204.

    Article  Google Scholar 

  19. Qu K, Lee SW, Bian JS, Low CM, Wong TH. Hydrogen sulfide: neurochemistry and neurobiology. Neurochem Int. 2008;52(1–2):155–65.

    Article  CAS  Google Scholar 

  20. Abe K, Kimura H. The possible role of hydrogen sulfide as an endogenous neuromodulator. J Neurosci. 1996;16(3):1066–71.

    Article  CAS  Google Scholar 

  21. Lin JY, Zhang MW, Wang JG, Li H, Wei HY, Liu R, Dai G, Liao XX. Hydrogen sulfide improves neural function in rats following cardiopulmonary resuscitation. Exp Ther Med. 2016;11(2):577.

    Article  CAS  Google Scholar 

  22. Wang Q, Ishikawa T, Michiue T, Zhu BL, Guan DW, Maeda H. Stability of endogenous reference genes in postmortem human brains for normalization of quantitative real-time PCR data: comprehensive evaluation using geNorm, NormFinder, and BestKeeper. Int J Legal Med. 2012;126(6):943–52.

    Article  Google Scholar 

  23. Yuan Q, Wang J, Fang QH, Liu YY, Fan JY, Zhang SW, Ma YM. Attenuating effect of pretreatment with Yiqifumai on lipopolysaccharide-induced intestine injury and survival rate in rat. J Inflamm. 2011;8:10.

    Article  Google Scholar 

  24. Karanjia N, Geocadin RG. Post-cardiac arrest syndrome: update on brain injury management and prognostication. Curr Treat Options Neurol. 2011;13(2):191–203.

    Article  Google Scholar 

  25. Wang T, Tang W, Sun S, Xu T, Wang H, Guan J, Huang Z, Weil MH. Intravenous infusion of bone marrow mesenchymal stem cells improves brain function after resuscitation from cardiac arrest. Crit Care Med. 2008;36(11 Suppl):S486–91.

    Article  Google Scholar 

  26. Elliott VJ, Rodgers DL, Brett SJ. Systematic review of quality of life and other patient-centred outcomes after cardiac arrest survival. Resuscitation. 2011;82(3):247–56.

    Article  Google Scholar 

  27. Juan YS, Chuang SM, Kogan BA, Mannikarottu A, Huang CH, Leggett RE, Schuler C, Levin RM. Effect of ischemia/reperfusion on bladder nerve and detrusor cell damage. Int Urol Nephrol. 2009;41(3):513–21.

    Article  Google Scholar 

  28. Lambden S, Creagh-Brown BC, Hunt J, Summers C, Forni LG. Definitions and pathophysiology of vasoplegic shock. Critical Care. 2018;22(1):174.

    Article  Google Scholar 

  29. Loumaye E, Ferrer-Sueta G, Alvarez B, Rees JF, Clippe A, Knoops B, Radi R, Trujillo M. Kinetic studies of peroxiredoxin 6 from Arenicola marina: rapid oxidation by hydrogen peroxide and peroxynitrite but lack of reduction by hydrogen sulfide. Arch Biochem Biophys. 2011;514(1–2):1–7.

    Article  CAS  Google Scholar 

  30. Ran K, Tang ZG, Ding LP, Li SF, Chang YT. Effect of hydrogen sulfide-induced delayed preconditioning on glutathione S-transferase expression during myocardial ischemia-reperfusion in rats. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2011;40(5):535–9.

    CAS  PubMed  Google Scholar 

  31. Yamamoto J, Sato W, Kosugi T, Yamamoto T, Kimura T, Taniguchi S, Kojima H, Maruyama S, Imai E, Matsuo S, et al. Distribution of hydrogen sulfide (H(2)S)-producing enzymes and the roles of the H(2)S donor sodium hydrosulfide in diabetic nephropathy. Clin Exp Nephrol. 2013;17(1):32–40.

    Article  CAS  Google Scholar 

  32. Panthi S, Manandhar S, Gautam K. Hydrogen sulfide, nitric oxide, and neurodegenerative disorders. Transl Neurodegeneration. 2018;7:3.

    Article  Google Scholar 

  33. Yin WL, He JQ, Hu B, Jiang ZS, Tang XQ. Hydrogen sulfide inhibits MPP(+)-induced apoptosis in PC12 cells. Life Sci. 2009;85(7–8):269–75.

    Article  CAS  Google Scholar 

  34. Wallace JL, Vong L, McKnight W, Dicay M, Martin GR: Endogenous and exogenous hydrogen sulfide promotes resolution of colitis in rats. Gastroenterology 2009, 137(2):569–578, 578 e561.

  35. S T LK, T K IN. Hydrogen sulphide protects mouse pancreatic β-cells from cell death induced by oxidative stress, but not by endoplasmic reticulum stress. Br J Pharmacol. 2011;162(5):1171–8.

    Article  Google Scholar 

  36. Kim MW, Bang MS, Han TR, Ko YJ, Yoon BW, Kim JH, Kang LM, Lee KM, Kim MH. Exercise increased BDNF and trkB in the contralateral hemisphere of the ischemic rat brain. Brain Res. 2005;1052(1):16–21.

    Article  CAS  Google Scholar 

  37. Lang EM, Asan E, Plesnila N, Hofmann GO, Sendtner M. Motoneuron survival after C7 nerve root avulsion and replantation in the adult rabbit: effects of local ciliary neurotrophic factor and brain-derived neurotrophic factor application. Plast Reconstr Surg. 2005;115(7):2042–50.

    Article  CAS  Google Scholar 

  38. Perez-Navarro E, Gavalda N, Gratacos E, Alberch J. Brain-derived neurotrophic factor prevents changes in Bcl-2 family members and caspase-3 activation induced by excitotoxicity in the striatum. J Neurochem. 2005;92(3):678–91.

    Article  CAS  Google Scholar 

  39. Evans AJ, Thompson BC, Wallace GG, Millard R, O'Leary SJ, Clark GM, Shepherd RK, Richardson RT. Promoting neurite outgrowth from spiral ganglion neuron explants using polypyrrole/BDNF-coated electrodes. J Biomed Mater Res A. 2009;91(1):241–50.

    Article  Google Scholar 

  40. El Touny LH, Henderson F, Djakiew D. Biochanin a reduces drug-induced p75NTR expression and enhances cell survival: a new in vitro assay for screening inhibitors of p75NTR expression. Rejuvenation Res. 2010;13(5):527–37.

    Article  Google Scholar 

  41. Molloy NH, Read DE, Gorman AM. Nerve growth factor in cancer cell death and survival. Cancers. 2011;3(1):510–30.

    Article  Google Scholar 

Download references

Acknowledgements

The authors express their gratitude to the staff of Department of Emergency,the First Affiliated Hospital of Xiamen University and Xiamen University Laboratory Animal Center for their excellent technical support and constructive criticism. We are extremely grateful to senior technician Fu Chen and Xiu-qing Zheng for their valuable help.

Funding

No.

Availability of data and materials

The datasets used and/or analyzed during the current study are available from the corresponding author.

Author information

Author notes

  1. Jiyan Lin and Weicheng Wu contributed equally to this work.

Authors and Affiliations

  1. Emergency Department, The First Affiliated Hospital of Xiamen University, No 55, Zhenhai Rd, Xiamen, 361003, China

    Jiyan Lin, Weicheng Wu, Zhihong Xu, Siyao Liu, Wang Lu & Mandong Pan

Authors
  1. Jiyan Lin
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Weicheng Wu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Zhihong Xu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Siyao Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Wang Lu
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Mandong Pan
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

Jiyan Lin designed and guided the study. Weicheng Wu undertook all the western Blot and PCR tests in this experiment, and wrote the main manuscript text. Zhi-hong Xu and Si-yao Liu conducted the animal experiments. Wang Lu performed the histological examination of the brain. Man-dong Pan prepared all figures and data analysis, and was a major contributor in in writing the manuscript. All authors reviewed the manuscript. All authors read and approved the final manuscript.

Corresponding authors

Correspondence to Jiyan Lin or Mandong Pan.

Ethics declarations

Ethics approval and consent to participate

All animal experiments were performed according to the American experimental animal use guidelines (NIH Publications No. 80–23) and approved by the animal ethics committee of Xiamen University.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lin, J., Wu, W., Xu, Z. et al. Effects of NaHS and hydroxylamine on the expressions of brain-derived neurotrophic factor and its receptors in rats after cardiac arrest and cardiopulmonary resuscitation. Scand J Trauma Resusc Emerg Med 26, 109 (2018). https://doi.org/10.1186/s13049-018-0577-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s13049-018-0577-z

Keywords

Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine

ISSN: 1757-7241